Center for Whole-Person Research
Orlando, Florida, 32804, United States
NCT Number: NCT03686917
Participants will complete a survey before an educational session, during the "break" of an educational session, or after the session.
Looking for future studies?
Notify Me18 year–120 year
All sexes
Observational
Orlando, Florida, 32804, United States
Participants will be recruited from diabetes education sessions at selected locations and at FHMG physician practices. For the diabetes education setting, ta research team member will introduce this study to a group of patients before educational sessions, during "break" of the educational sessions, and after sessions. If the patient is interested, an envelope with the Invitation to Participant letter attached to it and the survey enclosed will be given to them. Also, a NOTE will be attached to the envelope with the instructions: "Please drop your completed survey in the drop-box at ___." The drop-box location will be identified within each setting and provided to the participants in the note or indicated verbally.
For patients at physician practices, an envelope with the Invitation to Participant letter attached to it and survey enclosed will be given by a staff member. Invitation to Participant letter contains all portions of the consent process. A NOTE will be attached to the envelope with the instructions: "Please drop your completed survey in the drop box at____." The drop-box location will be identified within each setting and provided to the participants in the note or indicated verbally. If patient does not meet the inclusion criteria, they will be asked to return the envelope to the staff member who provided it.
Patients will be provided with Invitation to Participate letter along with survey. The Invitation to Participate letter provides patients with study details including inclusion/exclusion criteria, duration of participation, procedures to ensure confidentiality, and an overview of voluntary participation conditions. Implied consent will be used. In addition to the Invitation to Participate letter, there is a statement at the top of the survey "return of completed surveys implies consent to participate in the study"
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Survey
Time frame: Survey administered one time at baseline during the single study visit.
Total score of 28 item survey. Survey scored using a 5-point scale: Strongly disagree, Disagree, Neutral, Agree, Strongly Agree
Time frame: Collected one time at baseline during the single study visit.
Self reported demographics, including age, gender, and race
Time frame: Collected one time at baseline during the single study visit.
4 item survey. Q1 is YES/NO. Q2-4 are Yes/No/Not Sure
Time frame: Collected one time at baseline during the single study visit.
9 items. Items are scored over an 11-point satisfaction scale with two response anchors of No Satisfaction at All / Completely Satisfied.
Time frame: Collected one time at baseline during the single study visit.
10 items, answers on a scale of 1-10, with one being "Poor" and 10 being "Excellent".
AdventHealth
Other
Validation of a CREATION Health Assessment Tool for Patients (CHAT-P) in a Diabetic Outpatient Population
Acronym: CHAT-P
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsNCT04255433
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial DetailsNCT03887936
Diabetes Mellitus, Diabetes Mellitus, Type 2
Houston, Texas, United States
View Trial DetailsNCT02251431
Cardiovascular Diseases, Chronic Disease
Dallas, Texas, United States
View Trial Details